Table 1 Characteristics of included patients
Variable | Value |
|---|---|
Age, yr | 63.93 (15.40) |
Male sex | 112 (51.61) |
Total bilirubin (umol/L) | 70.23 (84.11) |
Direct bilirubin (umol/L) | 50.17 (64.69) |
WBC (U/L) | 1.31 (3.72) |
PLT (U/L) | 200.95 (81.91) |
ALT (U/L) | 134.27 (178.83) |
AST U/L) | 171.87 (187.38) |
Albuminemia (g/L) | 38.74 (23.86) |
Preoperative CA 19 − 9, U/mL | 518.43 (1712.87) |
Combines comorbid, n (%) | |
Cardiovascular disease | 42 (19.36) |
Diabetes mellitus | 15 (6.91) |
COPD | 10 (4.61) |
MT | 6 (2.76) |
Others | 11 (5.07) |
Indication of ERCP, n (%) | |
CBD stone | 177 (81.57) |
Pancreatic neoplasm | 24 (11.06) |
Cholangiocarcinoma | 8 (3.69) |
Others | 8 (3.69) |
Type of Papillary, n (%) | |
Type 1 | 115(52.99) |
Type 2 | 29 (13.36) |
Type 3 | 52 (23.96) |
Type 4 | 21 (9.69) |
PEP prophylaxis, n (%) | |
Somatostatin | 98(45.16) |
Pancreatic stents | 7 (3.23) |
Indomethacin | 48(22.12) |